ATE120800T1 - Antigen-protein der sporozoit- und hepatischen phase von p. falciparum. - Google Patents
Antigen-protein der sporozoit- und hepatischen phase von p. falciparum.Info
- Publication number
- ATE120800T1 ATE120800T1 AT90400985T AT90400985T ATE120800T1 AT E120800 T1 ATE120800 T1 AT E120800T1 AT 90400985 T AT90400985 T AT 90400985T AT 90400985 T AT90400985 T AT 90400985T AT E120800 T1 ATE120800 T1 AT E120800T1
- Authority
- AT
- Austria
- Prior art keywords
- glu
- lys
- ser
- asp
- gly
- Prior art date
Links
- 241000223960 Plasmodium falciparum Species 0.000 title abstract 2
- 210000003046 sporozoite Anatomy 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002440 hepatic effect Effects 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8904847A FR2645877B1 (fr) | 1989-04-12 | 1989-04-12 | Molecules comportant au moins une sequence peptidique porteuse d'un, ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum au niveau du stade sporozoite et dans les hepatocytes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE120800T1 true ATE120800T1 (de) | 1995-04-15 |
Family
ID=9380650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT90400985T ATE120800T1 (de) | 1989-04-12 | 1990-04-10 | Antigen-protein der sporozoit- und hepatischen phase von p. falciparum. |
Country Status (9)
Country | Link |
---|---|
US (2) | US5690941A (de) |
EP (1) | EP0407230B1 (de) |
AT (1) | ATE120800T1 (de) |
AU (1) | AU640923B2 (de) |
DE (1) | DE69018325D1 (de) |
FR (1) | FR2645877B1 (de) |
NZ (1) | NZ233328A (de) |
PT (1) | PT93764B (de) |
ZA (1) | ZA902831B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2672290B1 (fr) | 1991-02-05 | 1995-04-21 | Pasteur Institut | Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t. |
US6270771B1 (en) | 1988-10-06 | 2001-08-07 | Institut Pasteur | Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes |
CA2037151A1 (en) * | 1990-03-23 | 1991-09-24 | F. Hoffmann-La Roche Ag | Plasmodium sporozoite antigen |
US20030161840A1 (en) * | 1992-10-19 | 2003-08-28 | Institut Pasteur | Plasmodium falciparum antigens inducing protective antibodies |
FR2697022B1 (fr) | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
FR2744724B1 (fr) * | 1996-02-14 | 2002-08-02 | Pasteur Institut | Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques |
US20030104003A1 (en) * | 2001-05-25 | 2003-06-05 | James Anthony A. | Novel surface protein of the malaria parasite plasmodium falciparum |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535058A (en) * | 1982-10-01 | 1985-08-13 | Massachusetts Institute Of Technology | Characterization of oncogenes and assays based thereon |
US4584268A (en) * | 1981-10-13 | 1986-04-22 | Ceriani Roberto Luis | Method and compositions for carcinoma diagnosis |
US4666845A (en) * | 1983-12-16 | 1987-05-19 | Sloan-Kettering Institute | Monoclonal antibodies to ovarian, cervical and uterine human cancers and method of diagnosis |
US4687734A (en) * | 1984-06-07 | 1987-08-18 | Chester Samuel J | Immunoassay for the detection of human colon cancer using a polyclonal antibody derived from a capillary culture of tumor cells |
US4708930A (en) * | 1984-11-09 | 1987-11-24 | Coulter Corporation | Monoclonal antibody to a human carcinoma tumor associated antigen |
IS1355B6 (is) * | 1984-11-12 | 1989-04-19 | Lister Institute Of Preventive Medicine | Fjölkjarna kannar |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
WO1986006494A2 (fr) * | 1985-05-02 | 1986-11-06 | Pasteur Institut | Moyens pour le diagnostic in vitro de cellules malignesorigi naires du tube digestif |
US5188967A (en) * | 1985-05-02 | 1993-02-23 | Institut Pasteur | Agents for the in vitro diagnosis of malignant cells originating in the digestive tract |
US4725538A (en) * | 1985-10-25 | 1988-02-16 | The Beth Israel Hospital Association | Method of assaying the presence of cancer cells |
US5112749A (en) * | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
-
1989
- 1989-04-12 FR FR8904847A patent/FR2645877B1/fr not_active Expired - Lifetime
-
1990
- 1990-04-10 DE DE69018325T patent/DE69018325D1/de not_active Expired - Lifetime
- 1990-04-10 EP EP90400985A patent/EP0407230B1/de not_active Expired - Lifetime
- 1990-04-10 AT AT90400985T patent/ATE120800T1/de not_active IP Right Cessation
- 1990-04-11 AU AU53157/90A patent/AU640923B2/en not_active Ceased
- 1990-04-12 PT PT93764A patent/PT93764B/pt not_active IP Right Cessation
- 1990-04-12 NZ NZ233328A patent/NZ233328A/xx unknown
- 1990-04-12 ZA ZA902831A patent/ZA902831B/xx unknown
-
1994
- 1994-05-13 US US08/242,060 patent/US5690941A/en not_active Expired - Fee Related
-
1997
- 1997-04-14 US US08/837,098 patent/US6100067A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ZA902831B (en) | 1991-02-27 |
FR2645877B1 (fr) | 1991-07-05 |
FR2645877A1 (fr) | 1990-10-19 |
EP0407230B1 (de) | 1995-04-05 |
EP0407230A1 (de) | 1991-01-09 |
AU640923B2 (en) | 1993-09-09 |
PT93764B (pt) | 1996-08-30 |
PT93764A (pt) | 1990-11-20 |
NZ233328A (en) | 1993-01-27 |
US6100067A (en) | 2000-08-08 |
AU5315790A (en) | 1990-10-18 |
DE69018325D1 (de) | 1995-05-11 |
US5690941A (en) | 1997-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0644202T3 (da) | Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus | |
DK0419182T4 (da) | Nyt HCV-isolat J 1 | |
ES557358A0 (es) | Un metodo para la deteccion de anticuerpos especificos de un virus lav en un fluido biologico. | |
ATE319091T1 (de) | Diagnose von einheimischer sprue/zöliakie mit hilfe von gliadinepitopen | |
RU93058449A (ru) | Hcv геномные последовательности для диагностических и терапевтических целей | |
DK0523395T3 (da) | Seroreaktive områder på proteinerne E1 og E2 i HPV 16 | |
AU1342888A (en) | Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by P.Falciparum in hepatocytes and compositions containing them | |
ATE171710T1 (de) | Hcv peptidantigene und verfahren zur bestimmung von hcv | |
DE69033453D1 (de) | Rekombinante Polypeptide und Peptide, dafür kodierende Nukleinsäuren und ihre Verwendung in der Tuberkulose-Diagnose | |
FR2672290B1 (fr) | Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t. | |
DE69018325D1 (de) | Antigen-Protein der Sporozoit- und hepatischen Phase von P. falciparum. | |
IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
ATE103979T1 (de) | Menschliches lymphotoxin. | |
ATE202114T1 (de) | Verwendung von peptiden welche eine immunantwort bewirken zur herstellung von medikamenten zur induzierung der immunsuppression. | |
DK0426314T3 (da) | HIV-relaterede peptider | |
SG145521A1 (en) | Synthetic antigens for the detection of antibodies to hepatitis c virus | |
TH4070EX (th) | ลำดับ dna ที่มีรหัสของเซอร์เฟสแอนติเจนโปรตีน p31 ที่ดัดแปลงของไวรัสเฮพพาทิทิส บี |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |